Relapsing Nephrotic Syndrome Case: A Two Sided Pathway
DOI:
https://doi.org/10.71749/pkj.57Keywords:
COVID‐19Vaccines/adverseeffects, NephroticSyndromeAbstract
.
Downloads
References
Cancarevic I, Nassar M, Medina L, Sanchez A, Parikh A, Hosna A, et al. Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review. Cureus. 2022 Sep
Ahn W, Bomback AS. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020. Vol. 75, American Journal of Kidney Diseases. W.B. Saunders; 2020. p. 955–64.
Chandra P, Roldao M, Drachenberg C, Santos P, Washida N, Clark A, et al. Minimal change disease and COVID-19 vaccination: Four cases and review of literature. Clin Nephrol Case Stud. 2022 Jan 1;10(1):54–63.
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021 Oct 1;100(4):S1–276.
Castledine C, Tomlinson LA. Adjusting the Lens: Real World Outcomes in Nephrotic Syndrome. Vol. 6, Kidney International Reports. Elsevier Inc.; 2021. p. 246–7.
Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clinical Journal of the American Society of Nephrology. 2007 May;2(3):445–53.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Juliana Damas, Sara Cardoso Fernandes, Rui Barata, Mário Góis, Helena Sousa, Nuno Moreira Fonseca, Tiago Assis Pereira, João Sousa, Cristina Jorge (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.